Natalizumab Demonstrates Significant Impacts on Motor Fatigue in Relapsing MS

Using a cohort of more than 2000 pregnancies, the data showed an extremely rare number of major congenital anomalies while on ocrelizumab, as most patients underwent live birth with no issue.